{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T13:54:00Z","timestamp":1769003640504,"version":"3.49.0"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2022.1118683","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T10:45:20Z","timestamp":1671533120000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Editorial: Antimalarial chemotherapy in the XXIst century"],"prefix":"10.3389","volume":"13","author":[{"given":"Paula","family":"Gomes","sequence":"first","affiliation":[]},{"given":"Rafael V. C.","family":"Guido","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2022,12,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4380","DOI":"10.2174\/0929867324666170830103003","article-title":"New molecular targets and strategies for antimalarial discovery","volume":"26","author":"Aguiar","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"New Eng. J. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","article-title":"Evidence of artemisinin-resistant malaria in Africa","volume":"385","author":"Balikagala","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1038\/507S4a","article-title":"Infectious disease: Beating the big three","volume":"507","author":"Bourzac","year":"2014","journal-title":"Nat"},{"key":"B5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12936-016-1675-x","article-title":"New developments in anti-malarial target candidate and product profiles","volume":"16","author":"Burrows","year":"2017","journal-title":"Malar. J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.4155\/fmc.11.91","article-title":"Challenges in antimalarial drug discovery","volume":"3","author":"Burrows","year":"2011","journal-title":"Future Med. Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1179\/2047773215Y.0000000013","article-title":"Killing the hypnozoite--drug discovery approaches to prevent relapse in Plasmodium vivax","volume":"109109","author":"Campo","year":"2015","journal-title":"Pathog. Glob. Health"},{"key":"B8","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jgar.2021.09.001","article-title":"New insights into the spread of resistance to artemisinin and its analogues","volume":"27","author":"Noreen","year":"2021","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"B9","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12936-017-1917-6","article-title":"Efficacy and safety evaluation of a novel trioxaquine in the management of cerebral malaria in a mouse model","volume":"16","author":"Odhiambo","year":"2017","journal-title":"Malar. J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.drudis.2018.08.006","article-title":"New leads for drug repurposing against malaria","volume":"24","author":"Pazhayam","year":"2019","journal-title":"Drug Discov. Today"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/S1473-3099(21)00168-7","article-title":"Has artemisinin resistance emerged in Africa?","volume":"21","author":"Rosenthal","year":"2021","journal-title":"Lancet Inf. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/molecules25010066","article-title":"Cinnamic acid conjugates in the rescuing and repurposing of classical antimalarial drugs","volume":"25","author":"Silva","year":"2020","journal-title":"Molecules"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","article-title":"Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda","volume":"26","author":"Uwimana","year":"2020","journal-title":"Nat. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pt.2020.09.011","article-title":"Triple artemisinin-based combination therapies for malaria \u2013 a new paradigm?","volume":"1","author":"van der Pluijm","year":"2021","journal-title":"Trends Parasitol."},{"key":"B15","article-title":"WHO World malaria report 2021","year":"2021"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1118683\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T15:05:52Z","timestamp":1673363152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1118683\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,20]]},"references-count":15,"alternative-id":["10.3389\/fphar.2022.1118683"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.1118683","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,20]]},"article-number":"1118683"}}